Milestone Pharmaceuticals
IPOMontreal, Canada · Founded 2003 · $125.0M raised
- Headquarters
- Montreal
- Employees
- 11–50
- Founded
- 2003
- Business Model
- B2C
- Website
- milestonepharma.com
- Total Funding
- $125.0M
- Last Round
- $125.0M Growth EquityMar 2023
- Rounds
- 4
About
Biopharmaceutical company developing cardiovascular medicines, notably etripamil for paroxysmal supraventricular tachycardia.
Summary
Milestone Pharmaceuticals is a Biotech company based in Montreal, Canada, founded in 2003. It has raised $125.0M in total across 4 rounds, most recently a $125.0M Growth Equity round in Mar 2023. Investors include RTW Investments, Novo Holdings A/S and Forbion Capital Partners.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...